UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis

Frontiers in immunology, 2020-05, Vol.11, p.613-613

2020

Volltextzugriff (PDF)

Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5936

2024

Volltextzugriff (PDF)

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9142

2021

Volltextzugriff (PDF)

Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells

International journal of oncology, 2012-12, Vol.41 (6), p.2128-2138

2012

Volltextzugriff (PDF)

DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells

Immunology letters, 2018-06, Vol.198, p.7-11

2018

Volltextzugriff (PDF)

Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis

Annals of clinical and translational neurology, 2021-03, Vol.8 (3), p.656-665

2021

Volltextzugriff (PDF)

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Proceedings of the National Academy of Sciences - PNAS, 2022-02, Vol.119 (5)

2022

Volltextzugriff (PDF)

Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins

BioFactors (Oxford), 2019-05, Vol.45 (3), p.318-325

2019

Volltextzugriff (PDF)

Biomarkers of minimal residual disease in rituximab‐treated patients with mixed cryoglobulinemia

Biotechnology and applied biochemistry, 2021-04, Vol.68 (2), p.319-329

2021

Volltextzugriff (PDF)

Cryoglobulins: putative effectors of adaptive immune response

Clinical and Experimental Rheumatology, 2021-03, Vol.39 Suppl 129 (2), p.171-179

2021

Volltextzugriff (PDF)

Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia

Blood, 2017-07, Vol.130 (1), p.35-38

2017

Volltextzugriff (PDF)

Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody

Clinical and experimental rheumatology, 2016-01, Vol.34 (3 Suppl 97), p.S28

2016

Volltextzugriff (PDF)

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells

Immunologic research, 2014-12, Vol.60 (2-3), p.330-338

2014

Volltextzugriff (PDF)

Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects

Frontiers in immunology, 2015, Vol.6, p.4-4

2015

Volltextzugriff (PDF)

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21^sup low^ B cells

Immunologic research, 2014-12, Vol.60 (2-3), p.330

2014

Volltextzugriff (PDF)

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21 super(low) B cells

Immunologic research, 2014-12, Vol.60 (2-3), p.330-338

2014

Volltextzugriff (PDF)

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21low B cells

Immunologic research, 2014-12, Vol.60 (2-3), p.330-338

2014

Volltextzugriff (PDF)

Reversion of anergy signatures in clonal CD21 low B cells of mixed cryoglobulinemia after clearance of HCV viremia

Blood, 2017-07, Vol.130 (1), p.35

2017

Volltextzugriff (PDF)

1918-2018: 100 Years of Theater Research in Iași. International Conference of Doctoral School for Theater and Performing Arts and the Research Center of The Faculty of Theater at the George Enescu National University of Arts

2018

Volltextzugriff (PDF)

Hypoxic suppression of E. coli-induced NF-kappa B and AP-1 transactivation by oxyradical signaling

American journal of physiology. Regulatory, integrative and comparative physiology, 2004-08, Vol.287 (2), p.R437-R445

2004

Volltextzugriff (PDF)

Hypoxic suppression of E. coli-induced NF-κB and AP-1 transactivation by oxyradical signaling

American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Vol.56 (2), p.R437-R445

2004

Volltextzugriff (PDF)

Hypoxic suppression of E. coli-induced NF-{kappa}B and AP-1 transactivation by oxyradical signaling

American journal of physiology. Regulatory, integrative and comparative physiology, 2004-08, Vol.287 (2), p.R437

2004

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)
Bücher
(1)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis

Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis

Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells

DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells

Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins

Biomarkers of minimal residual disease in rituximab‐treated patients with mixed cryoglobulinemia

Cryoglobulins: putative effectors of adaptive immune response

Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia

Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells

Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21^sup low^ B cells

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21 super(low) B cells

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21low B cells

Reversion of anergy signatures in clonal CD21 low B cells of mixed cryoglobulinemia after clearance of HCV viremia

1918-2018: 100 Years of Theater Research in Iași. International Conference of Doctoral School for Theater and Performing Arts and the Research Center of The Faculty of Theater at the George Enescu National University of Arts

Hypoxic suppression of E. coli-induced NF-kappa B and AP-1 transactivation by oxyradical signaling

Hypoxic suppression of E. coli-induced NF-κB and AP-1 transactivation by oxyradical signaling

Hypoxic suppression of E. coli-induced NF-{kappa}B and AP-1 transactivation by oxyradical signaling

Suchergebnisse filtern